TY - JOUR
T1 - Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation
T2 - a role for transcellular biosynthesis of cysteinyl-leukotrienes.
AU - Di Gennaro, Antonio
AU - Carnini, Chiara
AU - Buccellati, Carola
AU - Ballerio, Rossana
AU - Zarini, Simona
AU - Fumagalli, Francesca
AU - Viappiani, Serena
AU - Librizzi, Laura
AU - Hernandez, Alicia
AU - Murphy, Robert C.
AU - Constantin, Gabriela
AU - De Curtis, Marco
AU - Folco, Giancarlo
AU - Sala, Angelo
PY - 2004
Y1 - 2004
N2 - We studied the effect of intravascular activation of human neutrophils on the synthesis of cysteinyl leukotrienes (cysLT) and the formation of cerebral edema in guinea-pig brains. Challenge with the chemotactic formylated tripeptide fMLP (0.1 microM) of neutrophil-perfused brain in vitro resulted in blood-brain barrier disruption associated with a significant increase of cysLT. Both events were completely prevented by neutrophil pretreatment with a specific 5-lipoxygenase (5-LO) inhibitor. Perfusion with the 5-LO metabolite leukotriene B4 (10 nM), together with neutrophils treated with the 5-LO inhibitor, did not restore the alteration in permeability observed upon perfusion with untreated and activated neutrophils. The dual cysLT1-cysLT2 receptor antagonist BAYu9773 was more potent and more effective than a selective cysLT1 antagonist in preventing the brain permeability alteration induced by neutrophil activation. RT-PCR showed significant expression of cysLT2 receptor mRNA in human umbilical vein endothelial cells. Intravital microscopy in mice showed that inhibition of leukotriene synthesis significantly reduced firm adhesion of neutrophils to cerebral vessels without affecting rolling. These data support the hypothesis that neutrophil and endothelial cells cooperate toward the local synthesis of cysLT within the brain vasculature and, acting via the cysLT2 receptor on endothelial cells, may represent a contributing pathogenic mechanism in the development of cerebral inflammation and edema.
AB - We studied the effect of intravascular activation of human neutrophils on the synthesis of cysteinyl leukotrienes (cysLT) and the formation of cerebral edema in guinea-pig brains. Challenge with the chemotactic formylated tripeptide fMLP (0.1 microM) of neutrophil-perfused brain in vitro resulted in blood-brain barrier disruption associated with a significant increase of cysLT. Both events were completely prevented by neutrophil pretreatment with a specific 5-lipoxygenase (5-LO) inhibitor. Perfusion with the 5-LO metabolite leukotriene B4 (10 nM), together with neutrophils treated with the 5-LO inhibitor, did not restore the alteration in permeability observed upon perfusion with untreated and activated neutrophils. The dual cysLT1-cysLT2 receptor antagonist BAYu9773 was more potent and more effective than a selective cysLT1 antagonist in preventing the brain permeability alteration induced by neutrophil activation. RT-PCR showed significant expression of cysLT2 receptor mRNA in human umbilical vein endothelial cells. Intravital microscopy in mice showed that inhibition of leukotriene synthesis significantly reduced firm adhesion of neutrophils to cerebral vessels without affecting rolling. These data support the hypothesis that neutrophil and endothelial cells cooperate toward the local synthesis of cysLT within the brain vasculature and, acting via the cysLT2 receptor on endothelial cells, may represent a contributing pathogenic mechanism in the development of cerebral inflammation and edema.
UR - http://www.scopus.com/inward/record.url?scp=4544275829&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4544275829&partnerID=8YFLogxK
M3 - Article
C2 - 15001558
AN - SCOPUS:4544275829
VL - 18
SP - 842
EP - 844
JO - FASEB Journal
JF - FASEB Journal
SN - 0892-6638
IS - 7
ER -